NCT02594800View on ClinicalTrials.gov

Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 21, 2015

Primary Completion Date

July 12, 2018

Study Completion Date

June 30, 2019

Conditions
Atherosclerosis
Interventions
DRUG

Rosuvastatin

standard or intensive dose rosuvastatin therapy based on other routine medication for stroke for 52 weeks.

Trial Locations (1)

310000

The second affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT02594800 - Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis | Biotech Hunter | Biotech Hunter